Higher Age (≥60 Years) Increases the Risk for Adverse Events during Autologous Hematopoietic Stem Cell Transplantation

Higher Age (≥60 Years) Increases the Risk for Adverse Events during Autologous Hematopoietic Stem Cell Transplantation

Autologous hematopoietic stem cell transplantation (autoHSCT) is a standard of care for patients with hemato-oncologic diseases. This procedure is highly regulated, and a quality assurance system needs to be in place. Deviations from defined processes and outcomes are reported as adverse events (AEs...

Full description

Bibliographic Details
Main Authors: Monika Haubitz, Vittoria S. von Petersdorff, Ingrid Helsen, Claudio Brunold, Elisabeth Oppliger Leibundgut, Gabriela M. Baerlocher
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Cancers
Subjects:
autologous hematopoietic stem cell transplantation
transplant product
hematopoietic stem and progenitor cells
adverse events
adverse reactions
collection
Online Access:https://www.mdpi.com/2072-6694/15/5/1584

Internet

https://www.mdpi.com/2072-6694/15/5/1584

Similar Items